ARCH Venture Partners XII, LLC Transaction History

Date Transaction Value Shares Traded Form
Feb 15 2024
BUY
Open market or private purchase
$20,000,000 $6.25 p/Share
3,200,000

Also insider at

NMRA
Neumora Therapeutics, Inc.
RAPP
Rapport Therapeutics, Inc.
AVP

Arch Venture Partners Xii, LLC

> 10% Shareholder
Chicago, IL

Track Institutional and Insider Activities on PRME

Follow Prime Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRME shares.

Notify only if

Insider Trading

Get notified when an Prime Medicine, Inc. insider buys or sells PRME shares.

Notify only if

News

Receive news related to Prime Medicine, Inc.

Track Activities on PRME